Which ASDAS cut-off corresponds best to treatment intensification in patients with axial spondyloarthritis in daily practice? A prospective study from a clinical registry. [PDF]
Nezam El-Din R +3 more
europepmc +1 more source
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study. [PDF]
Zhang S +41 more
europepmc +1 more source
Seventeen-year reassessment of diagnostic transitions, biologic therapy initiation and mortality in spondyloarthritis: results from the REGISPON-3 study. [PDF]
Puche-Larrubia MÁ +20 more
europepmc +1 more source
Osteitis condensans ilii masquerading as sacroiliitis: a case report of an underdiagnosed condition. [PDF]
Banjade RR +6 more
europepmc +1 more source
Correction to "Impact of Delay of Treatment With Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry". [PDF]
europepmc +1 more source

